Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality.
BMC Cancer. 2018 Jan 31;18(1):119. doi: 10.1186/s12885-018-4022-5.
BMC Cancer. 2018.
PMID: 29386014
Free PMC article.